BMY logo

Bristol-Myers Squibb (BMY) Cash from investing

annual CFI:

-$21.35B-$19.06B(-830.37%)
December 31, 2024

Summary

  • As of today (June 22, 2025), BMY annual cash flow from investing activities is -$21.35 billion, with the most recent change of -$19.06 billion (-830.37%) on December 31, 2024.
  • During the last 3 years, BMY annual CFI has fallen by -$20.81 billion (-3868.77%).
  • BMY annual CFI is now -520.40% below its all-time high of $5.08 billion, reached on December 31, 2008.

Performance

BMY Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYcash flow metrics

quarterly CFI:

-$499.00M-$303.00M(-154.59%)
March 31, 2025

Summary

  • As of today (June 22, 2025), BMY quarterly cash flow from investing activities is -$499.00 million, with the most recent change of -$303.00 million (-154.59%) on March 31, 2025.
  • Over the past year, BMY quarterly CFI has increased by +$19.12 billion (+97.46%).
  • BMY quarterly CFI is now -112.76% below its all-time high of $3.91 billion, reached on September 30, 2008.

Performance

BMY quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYcash flow metrics

TTM CFI:

-$2.23B+$19.12B(+89.54%)
March 31, 2025

Summary

  • As of today (June 22, 2025), BMY TTM cash flow from investing activities is -$2.23 billion, with the most recent change of +$19.12 billion (+89.54%) on March 31, 2025.
  • Over the past year, BMY TTM CFI has increased by +$19.47 billion (+89.71%).
  • BMY TTM CFI is now -143.97% below its all-time high of $5.08 billion, reached on December 31, 2008.

Performance

BMY TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BMY Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-830.4%+97.5%+89.7%
3 y3 years-3868.8%-625.3%-644.3%
5 y5 years-115.4%-181.8%+78.5%

BMY Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-3868.8%at low-141.1%+97.5%-945.8%+90.2%
5 y5-year-3868.8%at low-141.1%+97.5%-945.8%+90.2%
alltimeall time-520.4%at low-112.8%+97.5%-144.0%+90.2%

BMY Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$499.00M(+154.6%)
-$2.23B(-89.5%)
Dec 2024
-$21.35B(+830.4%)
-$196.00M(-10.5%)
-$21.35B(-5.1%)
Sep 2024
-
-$219.00M(-83.4%)
-$22.50B(-0.8%)
Jun 2024
-
-$1.32B(-93.3%)
-$22.69B(+4.6%)
Mar 2024
-
-$19.62B(+1357.5%)
-$21.70B(+845.7%)
Dec 2023
-$2.29B(+116.1%)
-$1.35B(+228.3%)
-$2.29B(-969.3%)
Sep 2023
-
-$410.00M(+24.6%)
$264.00M(-118.8%)
Jun 2023
-
-$329.00M(+56.7%)
-$1.41B(+2.9%)
Mar 2023
-
-$210.00M(-117.3%)
-$1.37B(+28.7%)
Dec 2022
-$1.06B(+97.4%)
$1.21B(-158.3%)
-$1.06B(-43.3%)
Sep 2022
-
-$2.08B(+620.1%)
-$1.87B(+143.7%)
Jun 2022
-
-$289.00M(-404.2%)
-$769.00M(+156.3%)
Mar 2022
-
$95.00M(-76.3%)
-$300.00M(-44.2%)
Dec 2021
-$538.00M(-95.0%)
$401.00M(-141.1%)
-$538.00M(-95.8%)
Sep 2021
-
-$976.00M(-642.2%)
-$12.75B(+6.4%)
Jun 2021
-
$180.00M(-225.9%)
-$11.99B(+3.2%)
Mar 2021
-
-$143.00M(-98.8%)
-$11.61B(+6.9%)
Dec 2020
-$10.86B(+9.5%)
-$11.81B(+5445.5%)
-$10.86B(-3.3%)
Sep 2020
-
-$213.00M(-138.3%)
-$11.23B(+6.7%)
Jun 2020
-
$556.00M(-8.9%)
-$10.52B(+1.5%)
Mar 2020
-
$610.00M(-105.0%)
-$10.36B(+4.5%)
Dec 2019
-$9.91B(+395.7%)
-$12.18B(-2580.4%)
-$9.91B(-1333.0%)
Sep 2019
-
$491.00M(-31.3%)
$804.00M(+384.3%)
Jun 2019
-
$715.00M(-32.5%)
$166.00M(-118.5%)
Mar 2019
-
$1.06B(-172.5%)
-$897.00M(-55.1%)
Dec 2018
-$2.00B(+2930.3%)
-$1.46B(+894.6%)
-$2.00B(-515.8%)
Sep 2018
-
-$147.00M(-57.8%)
$481.00M(-37.5%)
Jun 2018
-
-$348.00M(+709.3%)
$770.00M(+719.1%)
Mar 2018
-
-$43.00M(-104.2%)
$94.00M(-242.4%)
Dec 2017
-$66.00M(-104.5%)
$1.02B(+617.6%)
-$66.00M(-93.8%)
Sep 2017
-
$142.00M(-113.9%)
-$1.07B(-32.3%)
Jun 2017
-
-$1.02B(+404.4%)
-$1.58B(+959.7%)
Mar 2017
-
-$203.00M(-1368.8%)
-$149.00M(-110.1%)
Dec 2016
$1.48B(-194.1%)
$16.00M(-104.3%)
$1.48B(+208.3%)
Sep 2016
-
-$368.00M(-190.6%)
$480.00M(-38.9%)
Jun 2016
-
$406.00M(-71.5%)
$786.00M(-187.3%)
Mar 2016
-
$1.43B(-244.9%)
-$900.00M(-42.7%)
Dec 2015
-$1.57B(-229.3%)
-$984.00M(+1487.1%)
-$1.57B(+563.3%)
Sep 2015
-
-$62.00M(-95.2%)
-$237.00M(+2054.5%)
Jun 2015
-
-$1.28B(-269.8%)
-$11.00M(-95.5%)
Mar 2015
-
$754.00M(+114.8%)
-$242.00M(-119.9%)
Dec 2014
$1.22B(-312.6%)
$351.00M(+114.0%)
$1.22B(+121.1%)
Sep 2014
-
$164.00M(-110.9%)
$550.00M(-718.0%)
Jun 2014
-
-$1.51B(-168.3%)
-$89.00M(-106.0%)
Mar 2014
-
$2.21B(-802.2%)
$1.48B(-358.6%)
Dec 2013
-$572.00M(-91.5%)
-$315.00M(-33.7%)
-$572.00M(-2960.0%)
Sep 2013
-
-$475.00M(-933.3%)
$20.00M(-100.5%)
Jun 2013
-
$57.00M(-64.6%)
-$3.71B(+4.8%)
Mar 2013
-
$161.00M(-41.9%)
-$3.54B(-47.4%)
Dec 2012
-$6.73B(+368.1%)
$277.00M(-106.6%)
-$6.73B(+3.3%)
Sep 2012
-
-$4.20B(-1959.7%)
-$6.51B(+163.6%)
Jun 2012
-
$226.00M(-107.5%)
-$2.47B(-18.4%)
Mar 2012
-
-$3.03B(-711.5%)
-$3.03B(+110.6%)
Dec 2011
-$1.44B(-62.3%)
$495.00M(-403.7%)
-$1.44B(-67.4%)
Sep 2011
-
-$163.00M(-50.9%)
-$4.41B(+33.7%)
Jun 2011
-
-$332.00M(-76.9%)
-$3.30B(+20.9%)
Mar 2011
-
-$1.44B(-42.0%)
-$2.73B(-28.4%)
Dec 2010
-$3.81B(-13.0%)
-$2.48B(-361.5%)
-$3.81B(+61.5%)
Sep 2010
-
$948.00M(+298.3%)
-$2.36B(-55.4%)
Jun 2010
-
$238.00M(-109.4%)
-$5.30B(-11.3%)
Mar 2010
-
-$2.52B(+145.3%)
-$5.97B(+36.4%)
Dec 2009
-$4.38B(-186.2%)
-$1.03B(-48.4%)
-$4.38B(+92.2%)
Sep 2009
-
-$1.99B(+354.1%)
-$2.28B(-163.0%)
Jun 2009
-
-$438.00M(-52.7%)
$3.62B(+1.2%)
Mar 2009
-
-$926.00M(-186.2%)
$3.58B(-29.6%)
Dec 2008
$5.08B(-2614.4%)
$1.07B(-72.5%)
$5.08B(+25.7%)
Sep 2008
-
$3.91B(-912.9%)
$4.04B(+672.3%)
Jun 2008
-
-$481.00M(-183.5%)
$523.00M(+42.5%)
Mar 2008
-
$576.00M(+1594.1%)
$367.00M(-281.7%)
Dec 2007
-$202.00M
$34.00M(-91.4%)
-$202.00M(-140.1%)
Sep 2007
-
$394.00M(-161.9%)
$504.00M(<-9900.0%)
DateAnnualQuarterlyTTM
Jun 2007
-
-$637.00M(-9200.0%)
-$2.00M(-100.4%)
Mar 2007
-
$7.00M(-99.1%)
$490.00M(+137.9%)
Dec 2006
$206.00M(-82.7%)
$740.00M(-760.7%)
$206.00M(-111.1%)
Sep 2006
-
-$112.00M(-22.8%)
-$1.86B(+11.7%)
Jun 2006
-
-$145.00M(-47.7%)
-$1.66B(>+9900.0%)
Mar 2006
-
-$277.00M(-79.1%)
-$15.00M(-101.3%)
Dec 2005
$1.19B(-173.4%)
-$1.32B(-1713.4%)
$1.19B(-50.4%)
Sep 2005
-
$82.00M(-94.5%)
$2.40B(+30.6%)
Jun 2005
-
$1.50B(+61.8%)
$1.84B(-2143.3%)
Mar 2005
-
$929.00M(-922.1%)
-$90.00M(-94.5%)
Dec 2004
-$1.62B(-32.9%)
-$113.00M(-76.5%)
-$1.62B(-34.9%)
Sep 2004
-
-$480.00M(+12.7%)
-$2.49B(-1.6%)
Jun 2004
-
-$426.00M(-29.4%)
-$2.53B(+5.5%)
Mar 2004
-
-$603.00M(-38.7%)
-$2.40B(-0.7%)
Dec 2003
-$2.42B(+19.2%)
-$984.00M(+88.9%)
-$2.42B(-0.1%)
Sep 2003
-
-$521.00M(+77.2%)
-$2.42B(+8.8%)
Jun 2003
-
-$294.00M(-52.6%)
-$2.23B(+8.0%)
Mar 2003
-
-$620.00M(-37.1%)
-$2.06B(+1.5%)
Dec 2002
-$2.03B(-58.3%)
-$986.00M(+202.5%)
-$2.03B(-200.1%)
Sep 2002
-
-$326.00M(+152.7%)
$2.03B(-139.3%)
Jun 2002
-
-$129.00M(-78.1%)
-$5.16B(+0.3%)
Mar 2002
-
-$589.00M(-119.2%)
-$5.14B(+5.7%)
Dec 2001
-$4.86B(<-9900.0%)
$3.07B(-140.9%)
-$4.86B(-41.2%)
Sep 2001
-
-$7.51B(+6669.4%)
-$8.27B(+1917.1%)
Jun 2001
-
-$111.00M(-64.2%)
-$410.00M(+2.8%)
Mar 2001
-
-$310.00M(-7.5%)
-$399.00M(-2593.8%)
Dec 2000
$16.00M(-102.1%)
-$335.00M(-196.8%)
$16.00M(+166.7%)
Sep 2000
-
$346.00M(-446.0%)
$6.00M(-101.4%)
Jun 2000
-
-$100.00M(-195.2%)
-$415.00M(-18.3%)
Mar 2000
-
$105.00M(-130.4%)
-$508.00M(-33.1%)
Dec 1999
-$759.00M(+119.4%)
-$345.00M(+360.0%)
-$759.00M(+24.6%)
Sep 1999
-
-$75.00M(-61.1%)
-$609.00M(-13.6%)
Jun 1999
-
-$193.00M(+32.2%)
-$705.00M(+31.0%)
Mar 1999
-
-$146.00M(-25.1%)
-$538.00M(+55.5%)
Dec 1998
-$346.00M(-35.0%)
-$195.00M(+14.0%)
-$346.00M(+15.3%)
Sep 1998
-
-$171.00M(+557.7%)
-$300.00M(-10.7%)
Jun 1998
-
-$26.00M(-156.5%)
-$336.00M(-4.3%)
Mar 1998
-
$46.00M(-130.9%)
-$351.00M(-34.0%)
Dec 1997
-$532.00M(-25.8%)
-$149.00M(-28.0%)
-$532.00M(+18.5%)
Sep 1997
-
-$207.00M(+404.9%)
-$449.00M(+27.6%)
Jun 1997
-
-$41.00M(-69.6%)
-$352.00M(-34.9%)
Mar 1997
-
-$135.00M(+104.5%)
-$541.00M(-24.5%)
Dec 1996
-$717.00M(+13.6%)
-$66.00M(-40.0%)
-$717.00M(-14.2%)
Sep 1996
-
-$110.00M(-52.2%)
-$836.00M(-4.3%)
Jun 1996
-
-$230.00M(-26.0%)
-$874.00M(+29.5%)
Mar 1996
-
-$311.00M(+68.1%)
-$675.00M(+7.0%)
Dec 1995
-$631.00M(-55.7%)
-$185.00M(+25.0%)
-$631.00M(-9.6%)
Sep 1995
-
-$148.00M(+377.4%)
-$698.00M(-50.5%)
Jun 1995
-
-$31.00M(-88.4%)
-$1.41B(-9.6%)
Mar 1995
-
-$267.00M(+6.0%)
-$1.56B(+9.6%)
Dec 1994
-$1.42B(+138.5%)
-$252.00M(-70.7%)
-$1.42B(+8.1%)
Sep 1994
-
-$861.00M(+378.3%)
-$1.32B(+153.8%)
Jun 1994
-
-$180.00M(+37.4%)
-$519.00M(+92.2%)
Mar 1994
-
-$131.00M(-9.7%)
-$270.00M(-54.8%)
Dec 1993
-$597.00M(-238.8%)
-$145.00M(+130.2%)
-$597.00M(-223.1%)
Sep 1993
-
-$63.00M(-191.3%)
$485.00M(+37.8%)
Jun 1993
-
$69.00M(-115.1%)
$352.00M(+295.5%)
Mar 1993
-
-$458.00M(-148.9%)
$89.00M(-79.3%)
Dec 1992
$430.00M(-24.7%)
$937.00M(-578.1%)
$430.00M(-169.8%)
Sep 1992
-
-$196.00M(+1.0%)
-$616.00M(+56.7%)
Jun 1992
-
-$194.00M(+65.8%)
-$393.00M(-235.5%)
Mar 1992
-
-$117.00M(+7.3%)
$290.00M(-49.2%)
Dec 1991
$571.00M(-448.2%)
-$109.00M(-503.7%)
$571.00M(-1602.6%)
Sep 1991
-
$27.00M(-94.5%)
-$38.00M(-60.8%)
Jun 1991
-
$489.00M(+198.2%)
-$97.00M(-72.4%)
Mar 1991
-
$164.00M(-122.8%)
-$352.00M(+114.6%)
Dec 1990
-$164.00M(-89.9%)
-$718.00M(+2143.8%)
-$164.00M(-129.6%)
Sep 1990
-
-$32.00M(-113.7%)
$554.00M(-5.5%)
Jun 1990
-
$234.00M(-33.5%)
$586.00M(+66.5%)
Mar 1990
-
$352.00M
$352.00M
Dec 1989
-$1.63B
-
-

FAQ

  • What is Bristol-Myers Squibb annual cash flow from investing activities?
  • What is the all time high annual CFI for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual CFI year-on-year change?
  • What is Bristol-Myers Squibb quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly CFI year-on-year change?
  • What is Bristol-Myers Squibb TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb TTM CFI year-on-year change?

What is Bristol-Myers Squibb annual cash flow from investing activities?

The current annual CFI of BMY is -$21.35B

What is the all time high annual CFI for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual cash flow from investing activities is $5.08B

What is Bristol-Myers Squibb annual CFI year-on-year change?

Over the past year, BMY annual cash flow from investing activities has changed by -$19.06B (-830.37%)

What is Bristol-Myers Squibb quarterly cash flow from investing activities?

The current quarterly CFI of BMY is -$499.00M

What is the all time high quarterly CFI for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly cash flow from investing activities is $3.91B

What is Bristol-Myers Squibb quarterly CFI year-on-year change?

Over the past year, BMY quarterly cash flow from investing activities has changed by +$19.12B (+97.46%)

What is Bristol-Myers Squibb TTM cash flow from investing activities?

The current TTM CFI of BMY is -$2.23B

What is the all time high TTM CFI for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high TTM cash flow from investing activities is $5.08B

What is Bristol-Myers Squibb TTM CFI year-on-year change?

Over the past year, BMY TTM cash flow from investing activities has changed by +$19.47B (+89.71%)
On this page